Literature DB >> 7355327

Propranolol-related bronchospasm in patients without history of asthma.

D S Fraley, F J Bruns, D P Segel, S Adler.   

Abstract

Three patients with no history of asthma or allergy developed bronchospasm while taking propranolol for hypertension. The bronchospasm was severe in all three and in one patient resulted in respiratory arrest. Since the bronchospasm was relieved with discontinuation of propranolol and supportive bronchodilator therapy, the bronchospasm was believed to be caused by propranolol. Furthermore, each patient was subsequently treated with other antihypertensive medications which, like propranolol, contain the stabilizer additive tartrazine. Bronchospasm did not recur, making it unlikely that tartrazine hypersensitivity caused this problem. Regardless of a negative history of asthma, therefore, life-threatening bronchospasm must be considered a possible complication of propranolol therapy.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7355327     DOI: 10.1097/00007611-198002000-00030

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  7 in total

Review 1.  Safety considerations in treating concomitant diseases in patients with asthma.

Authors:  L W Hunt
Journal:  Drug Saf       Date:  1998-05       Impact factor: 5.606

2.  Influence of intrinsic sympathomimetic activity on respiratory function during chronic beta blockade: comparison of propranolol and pindolol.

Authors:  R J Northcote; D Ballantyne
Journal:  Br Med J (Clin Res Ed)       Date:  1986-07-12

3.  Comparative effects of dilevalol and atenolol on lung function and airway response to methacholine in hypertensive subjects.

Authors:  L P Boulet; Y Lacourcière; J Milot; N Lampron
Journal:  Br J Clin Pharmacol       Date:  1990-06       Impact factor: 4.335

Review 4.  Adverse reactions and interactions with beta-adrenoceptor blocking drugs.

Authors:  R V Lewis; D G McDevitt
Journal:  Med Toxicol       Date:  1986 Sep-Oct

5.  Propranolol treatment of complicated hemangiomas.

Authors:  Derya Ozyörük; Emine Zengin
Journal:  Indian J Pediatr       Date:  2013-07-06       Impact factor: 1.967

Review 6.  Adverse reactions with beta-adrenoceptor blocking drugs. An update.

Authors:  R V Lewis; C Lofthouse
Journal:  Drug Saf       Date:  1993-10       Impact factor: 5.606

7.  Novel selective β1-adrenoceptor antagonists for concomitant cardiovascular and respiratory disease.

Authors:  Jillian G Baker; Sheila M Gardiner; Jeanette Woolard; Christophe Fromont; Gopal P Jadhav; Shailesh N Mistry; Kevin S J Thompson; Barrie Kellam; Stephen J Hill; Peter M Fischer
Journal:  FASEB J       Date:  2017-04-11       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.